CAB DM
162 pág.

CAB DM


DisciplinaDietoterapia I962 materiais5.141 seguidores
Pré-visualização42 páginas
progression in type 2 diabetes. 
The New England Journal of Medicine, [S.l.], v. 363(3):233\u2013244, 2010.
CIULLA, T. A.; AMADOR, A. G; ZINMAN, B. Diabetic retinopathy and diabetic macular 
edema: pathophysiology, screening, and novel therapies. Diabetes Care, Alexandria, v. 26, 
n. 9, p. 2653\u20132664, 2003.
CLARKE, P. et al. Cost-effectiveness analysis of intensive blood-glucose control with metformin in 
overweight patients with type II diabetes (UKPDS No. 51). Diabetologia, [S.l.], v. 44, n. 3, p. 298\u2013304, 
2003.
COLHOUN, H. M. et al. Primary prevention of cardiovascular disease with atorvastatin in type 
2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised 
placebo-controlled trial. The Lancet, London, v. 364, n. 9435, p. 685\u2013696, 2004.
COLLINS, R. et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 
5963 people with diabetes: a randomised placebo-controlled trial. The Lancet, London, v. 361, 
n. 9374, p. 2005\u20132016, 2003.
COLQUHOUN, A. J. et al. Effectiveness of influenza vaccine in reducing hospital admissions in 
people with diabetes. Epidemiology and Infection, Cambridge, v. 119, n. 3, p. 335\u2013341, 1997.
CRYER, P. E. The barrier of hypoglycemia in diabetes. Diabetes , [S.l.], v. 57, v. 12, p. 3169\u20133176, 
2008.
DE BERARDIS, G. et al. Aspirin for primary prevention of cardiovascular events in people with 
diabetes: meta-analysis of randomised controlled trials. BMJ, [S.l.], v. 339, p. b4531, 2009.
85
Ministério da Saúde | Secretaria de Atenção à Saúde | Departamento de Atenção Básica
DHINDSA, S. et al. Testosterone concentrations in diabetic and nondiabetic obese men. 
Diabetes Care, Alexandria, v. 33, n. 6, p. 1186\u20131192, 2010.
DONNELLY, R. et al. ABC of arterial and venous disease: vascular complications of diabetes. 
BMJ, [S.l.], v. 320, n. 7241, p. 1062\u20131066, 2000.
DORA, J. M.; KRAMER, C. K.; CANANI, L. H. Standards of Medical Care in Diabetes \u20132008: 
response to Hirsch, Inzucchi, and Kirkman. Diabetes Care, Alexandria, v. 31, n. 5, p. e44-author 
reply e45, 2008.
DUNCAN, B. B. et al. Medicina Ambulatorial, Condutas de Atenção Primária Baseadas em 
Evidências. 4. ed. Porto Alegre: ArtMed, 2013.
EL-SERAG, H. B.; TRAN, T.; EVERHART, J. E. Diabetes increases the risk of chronic liver disease 
and hepatocellular carcinoma. Gastroenterology, [S.l.], v. 126, n. 2, p. 460\u2013468, 2004.
ESTACIO, R. O. et al. Effect of blood pressure control on diabetic microvascular 
complications in patients with hypertension and type 2 diabetes. Diabetes Care, Alexandria, 
v. 23, n. Suppl. 2, p. B54\u201364, 2000.
FONG, D. S. et al. Diabetic retinopathy. Diabetes Care, Alexandria, v. 26, n. 1, p. 226\u2013229, 2003.
GAEDE, P. et al. Multifactorial intervention and cardiovascular disease in patients with type 2 
diabetes. The New England Journal of Medicine, [S.l.], v. 348, n. 5, p. 383\u2013393, 2003.
GENZ, J, Scheer M, Trautner C, Zöllner I, Giani G, Icks A (2010) Reduced incidence of blindness in 
relation to diabetes mellitus in southern Germany? Diabet Medicine, [S.l.], v. 27, n. 10, p. 1138\u20131143, 
2010.
GILL, D. et al. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in 
adults. Cochrane database of systematic reviews, [S.l.], n. 10, p. CD009183, 2011.
GINSBERG, H. N. et al. Effects of combination lipid therapy in type 2 diabetes mellitus. The New 
England Journal of Medicine, [S.l.], v. 362, n. 17, p. 1563\u20131574, 2010.
GOINS, W. P. et al. A Comparison of 2 Strategies to Prevent Infection Following Pertussis 
Exposure in Vaccinated Healthcare Personnel. Clinical Infectious Diseases, Houston, v. 54, n. 7, 
p. 938-45, Apr. 2012. DOI: 10.1093/cid/cir973.
GROSS, J. L. et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care, 
Alexandria, v. 28, n. 1, p. 164\u2013176, 2005.
______. Screening for diabetic nephropathy: is measurement of urinary albumin to 
creatinine ratio worthwhile? Diabetes Care, Alexandria, v. 22, n. 9, p. 1599\u20131600, 1999.
HEART PROTECTION STUDY COLLABORATIVE GROUP. MRC/BHF Heart Protection Study 
of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised 
placebo controlled trial. The Lancet, London, v. 360, n. 9326, p. 7\u201322, 2002.
86
Ministério da Saúde | Secretaria de Atenção à Saúde | Departamento de Atenção Básica
HOLMAN, R. R. et al. 10-year follow-up of intensive glucose control in type 2 diabetes. The New 
England Journal of Medicine, [S.l.], v. 359, n. 15, p. 1577\u20131589, 2008.
HOWARD, A. A.; ARNSTEN, J. H.; GOUREVITCH, M. N. Effect of alcohol consumption on diabetes 
mellitus: a systematic review. Annals of Internal Medicine, Philadelphia, v. 140, n. 3, p. 211\u2013219, 
2004.
INCERTI, J. et al. Evaluation of tests for microalbuminuria screening in patients with diabetes. 
Nephrology Dialysis Transplantation, Oxford, v. 20, n. 11, p. 2402\u20132407, 2005.
JOHNSON, J. A. et al. Decreased mortality associated with the use of metformin compared 
with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care, Alexandria, v. 25, n. 12, 
p. 2244\u20132248, 2002.
JONES, S.; EDWARDS, R. T. Diabetic retinopathy screening: a systematic review of the economic 
evidence. Diabet Medicine, [S.l.], v. 27, n. 3, p. 249\u2013256, 2010.
KENGNE, A. P. et al. The Framingham and UK PROSPECTIVE DIABETES STUDY risk 
equations do not reliably estimate the probability of cardiovascular events in a 
large ethnically diverse sample of patients with diabetes: the Action in Diabetes and 
Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. 
Diabetologia, [S.l.], v. 53, n. 5, p. 821\u2013831, 2010.
KITABCHI, A. E. et al. Hyperglycemic crises in adult patients with diabetes: a consensus statement 
from the American Diabetes Association. Diabetes Care, Alexandria, v. 29, n. 12, p. 2739\u20132748, 2006.
KLEIN, B. E.; MOSS, S. E.; KLEIN, R. Effect of pregnancy on progression of diabetic retinopathy. 
Diabetes Care, Alexandria, v. 13, n. 1, p. 34\u201340, 1990.
KOHNER, E. M. et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at 
diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Archives of 
Ophthalmology, [S. l.], v. 116, n. 3, p. 297\u2013303, 1998.
KRAMER, C. K. Does bacteriuria interfere with albuminuria measurements of patients with 
diabetes? Nephrology Dialysis Transplantation, Oxford, v. 24, n. 4, p. 1193\u20131196, 2009.
KRAMER, C. K. et al. Clinical and laboratory profile of patients with type 2 diabetes with low 
glomerular filtration rate and normoalbuminuria. Diabetes Care, Alexandria, v. 30, n. 8, p. 1998\u20132000, 
2007.
MAGALHÃES, A. M.; CHIOCHETTA, F. V. Nursing diagnosis for patients with neurogenic bladder. 
Revista Gaúcha de Enfermagem, Porto Alegre, v. 23, n. 1, p. 6\u201318, 2002.
MAGEE, M. F.; BHATT, B. A. Management of decompensated diabetes. Diabetic ketoacidosis and 
hyperglycemic hyperosmolar syndrome. Critical Care Clinics, [Sl.], v. 17, n. 1, p. 75\u2013106, 2001.
MATTHEWS, D. R. et al. Risks of progression of retinopathy and vision loss related to tight 
blood pressure control in type 2 diabetes mellitus: UKPDS 69. Archives of Ophthalmology , [S.l.], 
v. 122, n. 11, p. 1631\u20131640, 2004.
87
Ministério da Saúde | Secretaria de Atenção a Saúde | Departamento de Atenção Básica
MCINTOSH, A. et al. Prevention and management of foot problems. Sheffield: University of 
Sheffield, 2003.
MCQUAY, H. et al. Anticonvulsant drugs for management of pain: a systematic review. BMJ, 
[S.l.], v. 311, n. 7012, p. 1047\u20131052, 1995.
MOLITCH, M. E. et al. Diabetic nephropathy. Diabetes Care, Alexandria, v. 26, n. Suppl. 1, p. S94\u201398, 
2003.
MOORE, R. A. et al. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. 
Cochrane database of systematic reviews, [S.l.], n. 3, p. CD007938, 2011.
MOSS, S. E.; KLEIN, R.; KLEIN, B. E. Ten-year incidence of visual